(Q35189569)

7 August 2017

1 reference

title

Hydroxynonenal, toxic carbonyls, and Alzheimer disease (English)

1 reference

7 August 2017

0 references

5

1 reference

7 August 2017

3

Mark A Smith

1 reference

7 August 2017

2

Arun K Raina

1 reference

7 August 2017

4

Lawrence M Sayre

1 reference

7 August 2017

Quan Liu

1

1 reference

7 August 2017

publication date

1 August 2003

1 reference

Molecular Aspects of Medicine

7 August 2017

published in

1 reference

7 August 2017

volume

24

1 reference

7 August 2017

issue

4-5

1 reference

7 August 2017

page(s)

305-313

1 reference

Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Carbonyl assays for determination of oxidatively modified proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Oxidative damage is the earliest event in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4-hydroxy-2-nonenal

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Carbonyl toxicology and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Neurofilament Accumulation Induced in Synapses by Leupeptin

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Pyrrole formation from 4-hydroxynonenal and primary amines

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Immunochemical evidence supporting 2-pentylpyrrole formation on proteins exposed to 4-hydroxy-2-nonenal

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Chemistry and biochemistry of oxidative stress in neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Preparation of neurofilament protein from guinea pig peripheral nerve and spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Radical AGEing in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Quantitative solubilization and analysis of insoluble paired helical filaments from Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Oxidative damage in Alzheimer's.

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Widespread peroxynitrite-mediated damage in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Risk of Alzheimer's disease and duration of NSAID use.

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification.

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

The role of mitogen-activated protein kinase pathways in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2803%2900025-6

7 January 2021

10.1016/S0098-2997(03)00025-6

Identifiers

DOI

1 reference

7 August 2017

1 reference